Amendment: SEC Form S-1/A filed by Alpha Capital Acquisition Company One
$ASPC
Business Services
Finance
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/21/2022 | Neutral | DA Davidson |
3 - ASPAC III Acquisition Corp. (0001890361) (Issuer)
3 - ASPAC III Acquisition Corp. (0001890361) (Issuer)
3 - ASPAC III Acquisition Corp. (0001890361) (Issuer)
DA Davidson initiated coverage of Aspec Technology, Inc. with a rating of Neutral
Gross Proceeds to Support Product Portfolio Enhancement and International Expansion Semantix to Begin Trading on Nasdaq Under the Ticker "STIX" on August 4th, 2022 Semantix, Inc. ("Semantix"), Latin America's first fully integrated data platform, today completed its previously announced business combination (the "Business Combination") with Alpha Capital ((ASPC), a special purpose acquisition company ("SPAC") focused on technology in Latin America. The Business Combination was approved by Alpha Capital shareholders on August 2, 2022. Semantix's ordinary shares and warrants will commence trading tomorrow, August 4, 2022, under the ticker symbols "STIX" and "STIXW", respectively, on Nasdaq
Transaction Expected to Close on August 3rd, 2022 Alpha Capital Acquisition Company ((ASPC), a special purpose acquisition company ("SPAC") focused on technology in Latin America, today announced that Alpha Capital's shareholders voted to approve its proposed business combination with Semantix, Latin America's first fully integrated data platform and Brazil's first deep tech company to be listed at Nasdaq. The vast majority of the votes cast at the meeting voted to approve the transaction. The business combination is scheduled to close on August 3, 2022 and the post-closing company will be renamed "Semantix, Inc." The common stock and warrants of the combined company are set to begin tra
Momentum Demonstrates Strong Track Record for Growth and Innovation Semantix, Latin America's first fully integrated data platform, announced today that the company has seen significant business momentum in the first half of 2022. These milestones align perfectly with the company's broader market strategy and include a combination of customer, partner, technological and operational growth for the business as it continues on its path to the public markets. Business Highlights Customer and partner growth continues to be at the center of Semantix's success. In the first half of 2022, the company: Added 41 new clients including leading players in the restaurant, clothing and home appliance
424B4 - ASPAC III Acquisition Corp. (0001890361) (Filer)
CERT - ASPAC III Acquisition Corp. (0001890361) (Filer)
8-A12B - ASPAC III Acquisition Corp. (0001890361) (Filer)
SC 13G/A - Alpha Capital Acquisition Co (0001836547) (Subject)
SC 13G - Alpha Capital Acquisition Co (0001836547) (Subject)
SC 13G - Alpha Capital Acquisition Co (0001836547) (Subject)
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. ECMOHO Limited (NASDAQ:MOHO) jumped 146.1% to settle at $0.4085 on above-average volume. Helius Medical Technologies, Inc. (NASDAQ:HSDT) shares climbed 145.3% to close at $1.58 on Wednesday after dropping 13% on Tuesday. Kaspien Holdings Inc. (NASDAQ:KSPN) jumped 140.3% to close at $6.20. Enveric Biosciences, Inc. (NASDAQ:ENVB) gained 106% to settle at $13.10. Enveric Biosciences recently announced an $8 million registered direct offering and private placement. Heart Test Laboratories, Inc. (NASDAQ:HSCS) jumped 89.6% to close at $3.28. Poseida Therapeutics
Gainers Helius Medical Technologies, Inc. (NASDAQ:HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. Kaspien Holdings Inc. (NASDAQ:KSPN) gained 112.4% to $5.48. Eargo, Inc. (NASDAQ:EAR) shares climbed 102.8% to $1.42. The company is scheduled to report Q2 earnings on Monday, August 8. Poseida Therapeutics, Inc. (NASDAQ:PSTX) shares jumped 99.6% to $4.85 as the company entered into a strategic collaboration and license agreement with Roche Holdings AG, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies. Applied DNA Sciences, Inc. (NASDAQ:APDN) climbed 75.7% to $4.92 on continued strength after the company initiated analytical validation
Wednesday's session saw 51 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows: Newmont (NYSE:NEM) was the largest company by market cap to set a new 52-week low. Benitec Biopharma (NASDAQ:BNTC) is the smallest company on a market cap basis to set a new 52-week low. Alpha Cap Acq (NASDAQ:ASPC) saw the largest move of the companies, as shares plummetted 28.22% to hit a new 52-week low. Mexico Fund (NYSE:MXF) saw the biggest bounce back on, as shares traded up 0.24% to rebound after it hit its new 52-week low. Here is a list of stocks that set new 52-week lows on Wednesday: Newmont (NYSE:NEM) stock hit a yearly low of $43.90. The stock was down 1.96% for